SCHEMBL6085264

SCHEMBL6085264

COC(=O)C1CC=CCC1C=O

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PRNP P04156 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CHRM2 P08172 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6085256 1.00 ALDH1A1 (0.33) ALDH1A1TSHRMEN1PRNPMAPK10
SCHEMBL6085259 1.00 ALDH1A1 (0.33) ALDH1A1TSHRMEN1PRNPMAPK10
SCHEMBL418068 0.81 GAA (0.41) ALDH1A1TSHRNPSR1RXFP1HSD17B10
SCHEMBL9308973 0.81 GAA (0.41) ALDH1A1TSHRNPSR1RXFP1HSD17B10
SCHEMBL418070 0.81 GAA (0.41) ALDH1A1TSHRNPSR1RXFP1HSD17B10
SCHEMBL13198671 0.81 GAA (0.41) ALDH1A1TSHRNPSR1RXFP1HSD17B10
SCHEMBL8246813 0.81 GAA (0.41) ALDH1A1TSHRNPSR1RXFP1HSD17B10
SCHEMBL15188991 0.77 GRM4 (0.35) ALDH1A1TSHRMEN1PRNPMAPK10
SCHEMBL8226501 0.75 — —
SCHEMBL9201745 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019149-B2 Thromboxane ligands without blood clotting side effects ALLERGAN, INC. (US) 2006-03-28 — — US disclosed
US-6818779-B2 TREATING OCULAR HYPOTENSION, HYPERTENSION, HEMORRHAGE, MYOCARDIAL ISCHEMIA, ANGINA PECTORIS, CORONARY CONTRACTION, CEREBROVASCULAR CONTRACTION AFTER SUBARACHNOIDAL HEMORRHAGE, CEREBRAL HEMORRHAGE AND ASTHMA WHICH COMPRISES ADMINISTERING ALLERGAN, INC. 2004-11-16 — — US disclosed
US-6462077-B1 OXABICYLCO COMPOUNDS; OCULAR HYPOTENSION, HYPERTENSION, HEMORRHAGE, MYOCARDIAL ISCHEMIA, ANGINA PECTORIS, CORONARY CONTRACTION, CEREBROVASCULAR CONTRACTION AFTER SUBARACH-NOIDAL HEMORRHAGE, CEREBRAL HEMORRHAGE, ASTHMA ALLERGAN, INC. 2002-10-08 — — US disclosed
Send feedback